Cargando…
siRNA Conjugated Nanoparticles—A Next Generation Strategy to Treat Lung Cancer
Despite major progress in both therapeutic and diagnostic techniques, lung cancer is still considered the leading cause of cancer mortality in the world due to the ineffectiveness of the classical treatments used nowadays. Luckily, the discovery of small interfering RNA (siRNA) planted hope in the h...
Autores principales: | Itani, Rasha, Al Faraj, Achraf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929195/ https://www.ncbi.nlm.nih.gov/pubmed/31816851 http://dx.doi.org/10.3390/ijms20236088 |
Ejemplares similares
-
Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients
por: Itani, Rasha, et al.
Publicado: (2020) -
Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?
por: Wang, Andrew Z.
Publicado: (2014) -
Generation and validation of structurally defined antibody–siRNA conjugates
por: Nanna, Alex R, et al.
Publicado: (2020) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012) -
Pegylated Gold Nanoparticles Conjugated with siRNA: Complexes Formation and Cytotoxicity
por: Okła, Elżbieta, et al.
Publicado: (2023)